Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT06347068 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Relapse
Resistant Cancer
Triple Negative Breast Cancer

Interventions

BIOLOGICAL: iC9-CAR.B7-H3 T Cell Therapy
DRUG: cyclophosphamide
DRUG: fludarabine

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]